Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. Terms of Reference. The Independent Expert Panel was established to undertake a systematic literature review of the roles of MDMA and psilocybin for the treatment of mental health conditions.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

AUGUST 3, 2021

There is no assurance that the use of psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Canna Care Docs

OCTOBER 3, 2023

Palliative Care and Symptom Management Referred to as palliative care, this medical caregiving approach helps to maximize the quality of life for patients and mitigate any physical or emotional suffering among people with serious and complex terminal illnesses.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

OCTOBER 13, 2021

Continued innovation, as demonstrated by our expanding IP portfolio, positions Cybin as a leading innovator in the development of putative psychedelic treatments for a variety of mental health conditions,” said Doug Drysdale, the company’s CEO. Vigorous scientific research and clinical trials are needed. About Cybin.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

The Cannigma

APRIL 12, 2023

Sleep is not often the focus of clinical trials on cannabis; rather it is often a secondary outcome. Anecdotal evidence may be not as bias free as research produced in a lab, but it is also more reflective of real world conditions. Has CBN been proven to help with sleep?

Sleep 133

Sleep Data Tincture Research and Development 133

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

FloridaMarijuana.net

AUGUST 15, 2018

A January 2018 Scientific American article titled “As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets” details a 2009 clinical trial in Canada which showed that the nighttime administration of THC reduced the frequency and intensity of nightmares in 72 percent of the 47 patients studied.”.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

MMJ Recs

NOVEMBER 30, 2023

Medical Marijuana for Epilepsy Treatment Medical marijuana, often referred to as MMJ, is a term used to describe the use of cannabis and its derivatives for therapeutic purposes. Medical marijuana has shown potential in treating a wide range of medical conditions, including epilepsy.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Veriheal

JULY 12, 2021

For veterans, PTSD (sometimes referred to as ‘shell shock’ or ‘combat stress’) can severely impact their livelihood. and 30% of deployed and non-deployed veterans screened positive for PTSD, which is why the condition has been made a priority through various initiatives. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. 28 Ketamine continues to show promise as a treatment option for conditions we had not yet considered. 9 How is ketamine commonly used?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

JULY 7, 2021

The power of the BioMAP Platform lies in the ability to compare a compound’s biological profile, or fingerprint, against a large reference database of profiles from approved drugs and tool compounds,” said Alison O’Mahony, Ph.D., This should remove the increased risk of infection, associated with all TNFi biological drugs used today.”.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Puff Puff Post

JANUARY 13, 2020

Sinai hospital performed clinical trials that used CBD to treat opiate addiction in both animal and human subjects. Sinai often refer patients to various studies if they believe it necessary. Canadian company, Tilray exports CBD oil to New York University for these trials. Physicians at Mt. Those studies are separate.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

Sinai hospital performed clinical trials that used CBD to treat opiate addiction in both animal and human subjects. Sinai often refer patients to various studies if they believe it necessary. Canadian company, Tilray exports CBD oil to New York University for these trials. Physicians at Mt. Those studies are separate.

CBD 52

CBD Clinical Trials Research and Development Oil 52

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming.

History 119

History Microdosing Research and Development Clinical Trials 119

Greencamp

FEBRUARY 17, 2019

Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . References. CBD and Glaucoma. and Nina M.

CBD 98

CBD THC Conditions Medicine 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

In fact, there are around 150 different cannabinoids that have been identified, all of which have their own unique characteristics and effects on the brain and body.The newest cannabinoid to take the stage is cannabinol, commonly referred to as CBN. CBN has the potential to treat many other conditions. Dental conditions.

Sleep 94

Sleep Cannabinoids THC CBD 94

Cannabis Law Report

NOVEMBER 15, 2021

References: Statement from then FDA Commissioner Scott Gottlieb, MD, and Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

CannaMD

AUGUST 26, 2020

Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD. Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

MARCH 17, 2022

It is an effective treatment for various health conditions such as chronic pain, nausea, seizures, and more. The health benefits of CBD oil can be applied to many aspects of our lives, from pain and anxiety relief in chronic illness to mental clarity for those who suffer from medical conditions like depression, Alzheimer’s disease, and PTSD.

Oil 52

Oil CBD Chronic Pain Extraction 52

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. Now, unless the patient is under 16 years old or has a history of drug abuse, medical practitioners in New South Wales can prescribe cannabis medicines without having to refer to a specialist.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. The trial is currently registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay. References.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

SEPTEMBER 8, 2021

EPN’s facility is capable of product development, manufacturing, and commercialization of cannabis consumer packaged goods in addition to the manufacture of products and formulations for use in clinical trials to a TGA and EU GMP standard. The conditions precedent for the execution of the Definitive Agreements are: a. .

Access 97

Access Research and Development Medicine THC 97

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. [2]. References. [1] CBD and Glaucoma.

CBD 52

CBD THC Conditions Medicine 52

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Sensi Seeds

NOVEMBER 23, 2018

Dr. Peter McGraw, a behavioural scientist, associate professor of marketing and psychology, and co-author of the book ‘The Humor Code’, posits that three conditions must be met for humour to occur. He referred to cannabis as “gelotophyllis”, which literally translates from Latin as “leaves of laughter”.

Blood Pressure 81

Blood Pressure Indica Clinical Trials Sativa 81

Cannabis Law Report

SEPTEMBER 24, 2019

We’re presuming both names “Epidyolex” & “Epidiolex” refer to exactly the same product and the former is the US product name and the latter the European brand name. Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. What about other medical cannabis products? “The

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. REFERENCE to the EU acquis. Draft Law of Ukraine. ARV (revised). explanatory note. Comparative table.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

CannaMD

AUGUST 8, 2020

When people say they’re buying or using “CBD,” they’re referring to products (most often oils) that are rich in this compound. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD.

CBD 100

CBD DEA Research and Development Hemp 100